Boston Scientific
770 hedge funds and large institutions have $52.3B invested in Boston Scientific in 2019 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 263 increasing their positions, 281 reducing their positions, and 64 closing their positions.
66% more call options, than puts
Call options by funds: $236M | Put options by funds: $142M
25% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 64
2% more funds holding
Funds holding: 757 → 770 (+13)
0.64% less ownership
Funds ownership: 92.83% → 92.19% (-0.64%)
6% less repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 281
6% less capital invested
Capital invested by funds: $55.4B → $52.3B (-$3.12B)
28% less funds holding in top 10
Funds holding in top 10: 18 → 13 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$292M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$157M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$90.5M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$83.5M |
| 5 |
BlackRock
New York
|
+$67.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$217M |
| 2 |
JP Morgan Chase
New York
|
-$161M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$93.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$91.1M |
| 5 |
Millennium Management
New York
|
-$77.3M |
BSX Hedge Fund Activity: Q3 2019 in Review
770 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2019, worth a combined $52.3B — down 5.6% from $55.4B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new BSX positions and 64 closed out — a net gain of 16 holders — while 263 added to existing stakes and 281 trimmed.
The largest buyer was Capital World Investors, adding an estimated $292M. The largest seller was Wellington Management Group, cutting an estimated $217M.
- 770 institutional investors held Boston Scientific (BSX) as of Q3 2019, up from 757 in Q2 2019.
- Funds reported $52.3B of Boston Scientific stock for Q3 2019, down 5.6% quarter-over-quarter.
- 80 funds opened new Boston Scientific positions in Q3 2019 and 64 closed out, a net change of +16 holders.
- The largest Boston Scientific buyer in Q3 2019 was Capital World Investors, an estimated $292M added.
- The largest Boston Scientific seller in Q3 2019 was Wellington Management Group, an estimated $217M sold.
Based on aggregated 13F filings for Q3 2019.